UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 
MOORESTOWN, N.J., March 21, 2017 -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ:TRHC), a disruptive innovation and technology leader in medication safety, offering a unique Medication Risk Stratification and Medication Risk Mitigation Matrix® suite of decision support tools, today announced that Chairman and CEO Calvin H. Knowlton, Ph.D. and Chief Financial Officer Brian Adams, will participate in the 16th Annual Needham Healthcare Conference.
Dr. Knowlton and Mr. Adams are scheduled to present at the conference on Tuesday, April 4, 2017 at 4:20 p.m. EDT. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com. The archived webcast and presentation materials will also be available for 90 days at the same URL.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC has focused on optimizing outcomes for PACE and other healthcare organizations through its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participant's medication regimen. For more information, please visit: www.TRHC.com.
Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected] Media Dianne Semingson 215-870-0829 [email protected]
